Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Filings indexed 789 across all filing types
Latest filing 2020-11-30 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
关于获得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the receipt of medical device registration certificates issued by a regulatory authority (Hebei Provincial Drug Administration). It details the product names, registration numbers, and validity periods. The document includes a risk warning about the impact of these registrations on future business. The document length is short (1302 characters) and it is an announcement of a regulatory approval rather than a financial report or detailed management discussion. It does not contain financial statements, earnings data, or management changes. Therefore, it fits best into the category of a Regulatory Filing (RNS), which is a general regulatory announcement that does not fit into more specific categories.
2020-11-30 Chinese
2020年第五次临时股东大会之法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the procedures, attendance, and voting results of the 2020 fifth extraordinary general meeting (临时股东大会) of 康泰医学系统(秦皇岛)股份有限公司. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, confirming compliance with relevant laws and company regulations. This is not the actual voting results announcement itself but a legal opinion on the meeting's legality and procedures. Given the content focuses on the legal opinion about the shareholder meeting and its voting process, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 4584 characters, which is sufficient to contain substantive content rather than a brief announcement or report publication notice. Therefore, the classification is DVA with high confidence.
2020-10-27 Chinese
2020年第五次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a resolution announcement for the 2020 fifth extraordinary shareholders' meeting of 康泰医学系统(秦皇岛)股份有限公司. It details the meeting date, attendance, voting results on specific proposals, and legal opinions confirming the validity of the meeting and voting process. There is no indication of it being a full annual or interim report, audit report, or earnings release. The content focuses on the official results of shareholder votes at a general meeting. The document length is about 2508 characters, which is consistent with a detailed voting results announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-10-27 Chinese
2020年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2020 Third Quarter Report" of 康泰医学系统(秦皇岛)股份有限公司, indicating it is a quarterly financial report. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and management discussion of financial performance for the third quarter of 2020. The length of the document (15,000 characters) and the presence of comprehensive financial statements and analysis confirm it is a full interim/quarterly report rather than a brief announcement or a certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). 9M 2020
2020-10-25 Chinese
关于2020年第三季度报告披露的提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (360 characters) stating that the company's 2020 third quarter report has been disclosed on an official website. It does not contain the actual financial data or substantive analysis but merely informs investors to refer to the full report elsewhere. According to the 'Menu vs Meal' rule, such a brief notice about report disclosure is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2020-10-25 Chinese
申万宏源证券承销保荐有限责任公司关于公司使用募集资金置换已预先投入募投项目及已支付发行费用的自筹资金的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion issued by the underwriting and sponsoring institution (申万宏源证券承销保荐有限责任公司) regarding the use of raised funds by 康泰医学系统(秦皇岛)股份有限公司 to replace self-raised funds previously invested in projects and paid issuance expenses. It references regulatory guidelines, approval by the board, supervisory board, independent directors, and an audit report by Deloitte. The document includes detailed financial figures related to the initial public offering (IPO) fundraising, the use of proceeds, and the replacement of self-raised funds with IPO proceeds. The document is not a full annual or interim report, nor is it a simple announcement. It is a specialized audit or verification report related to the use of funds raised in an IPO, consistent with the definition of an Audit Report / Information (AR). The document length is 4406 characters, which is relatively short but contains substantive audit and verification content rather than just an announcement or certification. Therefore, the best classification is AR (Audit Report / Information). Q3 2020
2020-10-12 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.